Zoetis has announced that the European Commission has granted marketing authorization for Simparica™ (sarolaner) chewable tablets, a once-monthly medication for the treatment of fleas, ticks and sarcoptic mange in dogs beginning at eight weeks of age…

Zoetis has announced the launch of Simparica, a once-monthly oral medication for the treatment of flea, tick and mite infestations in dogs beginning at eight weeks of age. 

The company says the new product, which comes in the form of a tasty chewable…

Zoetis has launched Stronghold Plus (selamectin/sarolaner), a topical combination of parasiticides that treats ticks, fleas, ear mites, lice and GI nematodes and prevents heartworm disease in cats.

Stronghold Plus contains the same selamectin found in…

Zoetis has launched Stronghold Plus (selamectin/sarolaner), a topical combination of parasiticides licensed for the treatment of fleas, ticks, ear mites, lice, GI worms and heartworm in cats.

Zoetis says the combined action of selamectin and sarolaner…

Zoetis has announced that Simparica, its once-monthly oral treatment for flea, tick and mite infestations in dogs, is now licensed for Otodectes Cynotis and Demodex Canis in addition to Sarcoptes Scabiei.

Launched in 2016, Simparica kills 95% of fleas…

Zoetis has announced that it plans to launch Simparica Trio (sarolaner/moxidectin/pyrantel) chewable tablets, a once-monthly triple combination antiparasitic medication for dogs with, or at risk from, mixed external and internal parasitic infestations…

Zoetis has announced the European launch of Simparica Trio (sarolaner/moxidectin/pyrantel), a once-monthly ecto- and endoparasticide for dogs.

The chewable, prescription-only tablet contains sarolaner, which kills fleas and ticks; moxidectin, for the prevention…

Zoetis has announced the launch of Vetscan Imagyst, a new in-clinic diagnostic tool initially for testing cats' and dogs' faecal samples for parasites but which has broader applications in the future. 

The company says the system uses a combination…

Zoetis has updated the packaging for Simparica Trio, its monthly chewable parasiticide for dogs.

The refreshed packaging keeps the same colour scheme, but the graphics indicating the product uses stand out better.

The company has also added an area on the…

Zoetis has announced that Simparica Trio is now licensed for the treatment of Angiostrongylus vasorum, aka lungworm in dogs.

This, the company says, makes Simparica Trio the only oral moxidectin that is licensed to treat A.vasorum in dogs in the UK. 

Louise Longstaff…